INVITAE CORPORATION, A MEDICAL GENETICS COMPANY that had a $1.34 billion loss during the nine months ending Sept. 30, 2023, recently announced coming actions to cut costs and change operations. The San Francisco-based company sold “certain reproductive health assets including carrier screening and non-invasive prenatal screening” to Natera, an Austin, Texas-based company offering cell-free DNA …
Invitae Cuts Costs to Rebuild Oncology Testing Pipeline Read More »
